Vit Prochazka

8PUBLICATIONS

75CO-AUTHORS

Haematological tumoursPredictive and prognostic markersLiquid biopsiesTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (8)

Sort by Publication Date:

|Jun 24, 2026

Efficacy of post-transplant brentuximab vedotin maintenance by pre-transplant disease status in relapsed/refractory classic Hodgkin lymphoma.

|Apr 14, 2026

Diagnosis-to-treatment interval is associated with outcomes in follicular lymphoma treated with immunochemotherapy.

Prokop Vodička, Tarec C El-Galaly, Vit Prochazka

|Dec 02, 2025

FLIPI24: A Modern Prognostic Model and Clinical Trial Enrichment Tool for Newly Diagnosed Follicular Lymphoma.

Matthew J Maurer, Vit K Prochazka, Tarec Christoffer El-Galaly

|Sep 26, 2025

Distinct cell state ecosystems for nodular lymphocyte-predominant Hodgkin lymphoma.

Ajay Subramanian, Shengqin Su, Jamie Flerlage

|Sep 20, 2023

Overall survival of patients with cHL who progress after autologous stem cell transplant: results in the novel agent era.

Sanjal H Desai, Michael A Spinner, Andrew M Evens

|Apr 22, 2023

Interim PET in follicular lymphoma: more patience, please.

Vít Procházka

Pageof 2

Frequent Collaborators

Brad S Kahl

Marek Trneny

Matthew J Maurer

Christopher R Flowers

Diego Villa

Peter de Nully Brown

Caroline E Dietrich

Robert Kridel

Chan Y Cheah

Eliza A Hawkes

Frequent Collaborators

Brad S Kahl

Marek Trneny

Matthew J Maurer

Christopher R Flowers